HIGHFDA DEVICE

Wondfo Streptococcal A At-Home Self-Test Recalled for FDA Clearance Issues (2026)

Wondfo recalled 188 units of Streptococcal A At-Home Self-Test sold nationwide in the United States after regulators found the device was not FDA-cleared. The recall centers on lack of FDA clearance for safety and effectiveness. Consumers should stop using the test immediately and contact Altruan GmbH or their healthcare provider for instructions.

Official notice
WondfoAltruan GmbHHealth & Personal CareMedical DevicesModel No. 41972No UDILot Code: 6933289812337

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DEVICE
Recall date
December 19, 2025
Status
ACTIVE
Severity
5/10

Quick Facts at a Glance

Recall Date
December 19, 2025
Hazard Level
HIGH
Brands
Wondfo, Altruan GmbH
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Medical Devices; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Wondfo, Altruan GmbH
Product type
Strep A At-Home Self-Test Kit
Model numbers
Model No. 41972, No UDI, Lot Code: 6933289812337
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    December 19, 2025

  2. Reported by FDA DEVICE

    March 18, 2026

  3. RecallRadar source check

    April 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Product not cleared by the FDA.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Altruan GmbH or your healthcare provider for instructions. Notification method: Other

About This Product

This is an at-home test kit intended to detect group A Streptococcus bacteria. Consumers purchase it for rapid, at-home screening of strep infections.

Why This Is Dangerous

The product has not been cleared by the FDA. That clearance normally assesses safety and effectiveness for its intended use. Without clearance, test results may be unreliable.

Industry Context

This recall is not described as part of a broader industry pattern in the provided information.

Real-World Impact

If the test yields inaccurate results, patients may delay treatment or undergo unnecessary antibiotic use, potentially harming health outcomes.

Practical Guidance

How to identify if yours is affected

  1. Check packaging for Model No. 41972
  2. Look for Lot Code 6933289812337
  3. Note the marking No UDI on the product

Where to find product info

Model, lot, and UDI information are typically located on the device packaging or label

What timeline to expect

The recall does not specify a refund timeline; consumers should contact the manufacturer for instructions

If the manufacturer is unresponsive

  • Document all communications with the manufacturer
  • If the company is unresponsive, file a consumer complaint with the FDA
  • Keep copies of the recall notice and any correspondence

How to prevent similar issues

  • Use FDA-cleared at-home tests when available
  • Verify clearance status before purchasing diagnostic tests
  • Follow manufacturer instructions and consult a healthcare provider if results are unclear

Documentation advice

Retain the recall notice, packaging photos, receipts, and any correspondence with the manufacturer

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

- Model No. 41972 - No UDI - Lot Code: 6933289812337 - Sold nationwide in the United States - Quantity: 188 units - Price: Unknown

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • FDA clearance issue noted
  • Discontinued nationwide in the US
  • Model No. 41972 and Lot 6933289812337 identified

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
5/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Details

Model Numbers
Model No. 41972
No UDI
Lot Code: 6933289812337
Affected States
ALL
Report Date
March 18, 2026
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

Taro Pharmaceuticals Withdraws Diclofenac Sodium Gel Over Viscosity Issues

Taro Pharmaceuticals announced a market withdrawal of Diclofenac Sodium, Topical Gel, 3% on January 27, 2026. The withdrawal stems from out of specification viscosity results. Healthcare providers and consumers should stop using the product immediately.

BEEKEEPER'S NATURALS USA
Microbial Contamination
Read more
Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more